Timothy K. Starr - Concepedia

Author

Timothy K. Starr

Also Known As

Starr, Timothy, Starr, Timothy K. ca. 20./21. Jh., T K Starr, T STARR, T. K. Starr, T. Starr, Tim K. Starr, Tim Starr, Timothy K. Starr, Timothy K Starr

190

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

University of Minnesota University of Minnesota Medical Center University of Iowa University of Minnesota, Duluth The University of Texas MD Anderson Cancer Center

About

Timothy K. Starr is an author at University of Minnesota specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	27	2.5K
2	Engineering	5	5	493
3	Natural Sciences	2	2	65
4	Public Health	1	1	44
5	Biomolecular Engineering	1	1	19

Timothy K. Starr

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Recurrent R-spondin fusions in colon cancer Somasekar Seshagiri, Eric Stawiski, Steffen Durinck, Nature	2012	967
A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer Timothy K. Starr, Raha Allaei, Kevin A.T. Silverstein, Science EngineeringGeneticsEpigeneticsTumor HeterogeneityCandidate Crc Genes	2009	354
Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment Michael B. Burns, Joshua Lynch, Timothy K. Starr, Genome Medicine DysbiosisColorectal Tumor MicroenvironmentVirulence FactorPathogenesisGut Microbiology	2015	241
A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma Vincent W. Keng, Augusto Villanueva, Derek Y. Chiang, Nature Biotechnology Mouse Hepatocellular CarcinomaHepatocellular CarcinomaOncogenic AgentPathologyLiver Cancer	2009	200
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy Emily J. Pomeroy, John Hunzeker, Mitchell G. Kluesner, Molecular Therapy Cancer ImmunosurveillanceImmunologyTherapeutic VaccineImmune Checkpoint InhibitorImmune Cell Therapy	2019	175
CFTR is a tumor suppressor gene in murine and human intestinal cancer B L N Than, Janneke F. Linnekamp, Timothy K. Starr, Oncogene Tumor BiologyGastrointestinal OncologyMedicineHuman Intestinal CancerTumor Suppressor Gene	2016	168
A Modified <i>Sleeping Beauty</i> Transposon System That Can Be Used to Model a Wide Variety of Human Cancers in Mice Adam J. Dupuy, Laura M. Rogers, Jinsil Kim, Cancer Research Transgenic Mouse ModelsImmunologyCancer BiologyTumor BiologyWide Variety	2009	166
APOBEC3A catalyzes mutation and drives carcinogenesis in vivo Emily K. Law, Rena Levin-Klein, Matthew C. Jarvis, The Journal of Experimental Medicine Somatic VariantOncogenic AgentMedicineApobec3 FamilyPathology	2020	150
Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis Ashutosh Tiwari, Kojiro Tashiro, Ajay Dixit, Gastroenterology Tumor BiologyPancreatic CancerMedicineCancer Cell BiologyCancer Biology	2020	140
Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells Boris Winterhoff, Makayla Maile, Amit Mitra, Gynecologic Oncology Tumor HeterogeneityMedicineSingle Cell SequencingOvarian Cancer EpitheliumPathology	2017	134

Page 1